Skip to main content
. 2021 Mar 12;2021:6621296. doi: 10.1155/2021/6621296

Figure 1.

Figure 1

IL-22 treatment ameliorated cerebral I/R injury. (a) Representative sections of TTC staining in each group (n = 6). (b) Quantification of infarct volume in each group (n = 6). (c) Neurological deficits were assessed in each group (n = 8). (d) Brain water content was calculated in each group (n = 6). P < 0.05 vs sham group; #P < 0.05 vs MCAO group.